CreatineRCT2001

Creatine supplementation alters the response to a graded cycle ergometer test.

European journal of applied physiology

confidence

Key findings

Creatine improved total test time and lowered VO2/HR at submaximal stages, raised ventilatory threshold; no change in peak VO2.

View source on PubMed (PMID 11072779) ↗

Sample size
36 (CS=19, PL=17)
Population
trained adults aged 21-27 years (20 male, 16 female)
Dosing
5 g creatine monohydrate four times daily (20 g/day)
Duration
7 days
Route
oral
Blinding
double_blind
Controls
placebo
Drug class
supplement

Measured endpoints

  • total test timeImprovedexercise_performance
    significanteffect: 1217 to 1289 s
  • oxygen consumption (VO2) at end of first five GXT stagesDecreasedrespiratory
    significant
  • heart rate at end of first five GXT stagesDecreasedcardiovascular
    significant
  • ventilatory threshold (VO2 at threshold)Increasedrespiratory
    significanteffect: 2.2 to 2.6 l x min(-1); 66% to 78% peak VO2
  • peak VO2No changeexercise_performance
    not_significanteffect: 3.4 to 3.3 l x min(-1)
Full abstract

To determine the effects of creatine supplementation on cardiorespiratory responses during a graded exercise test (GXT) 36 trained adults (20 male, 16 female; 21-27 years old) performed two maximal GXTs on a cycle ergometer. The first GXT was done in a nonsupplemented condition, and the second GXT was done following 7 days of ingesting either 5 g creatine monohydrate, encased in gelatin capsules, four times daily (CS, 13 male, 6 female), or the same number of glucose capsules (PL, 7 male, 10 female). CS significantly (P<0.05) improved total test time [pre-CS = 1217 (240) s, mean (std. dev.) versus post-CS = 1289 (215) s], while PL administration had no effect (P>0.05) on total test time [pre-PL= 1037 (181) s. versus post-PL= 1047 (172) s]. In addition, both oxygen consumption (VO2) and heart rate at the end of each of the first five GXT stages were significantly lower after CS, but were unchanged after PL. Moreover, the ventilatory threshold occurred at a significantly greater VO2 for CS [pre-CS = 2.2 (0.4) l x min(-1) or 66% of peak VO2 versus post-CS = 2.6 (0.5) l x min(-1) or 78% of peak Vo2; pre-PL = 2.6 (0.9) l x min(-1) or 70% peak VO2 versus post-PL = 2.6 (1.1) l x min(-1) or 68% of peak Vo2]. Neither CS nor PL had an effect on peak Vo2 [pre-CS = 3.4 (0.7) l x min(-1) versus post-CS = 3.3 (0.7) l x min(-1); pre-PL = 3.7 (1.1) l x min(-1) versus post-PL = 3.7 (1.1) l x min(-1)]. Apparently, CS can alter the contributions of the different metabolic systems during the initial stages of a GXT. Thus, the body is able to perform the sub-maximal workloads at a lower oxygen cost with a concomitant reduction in the work performed by the cardiovascular system.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.